Entrepreneurs try to upend the biotech funding model; Medicare advisers suggest tweaks to coverage process for Alzheimer’s drugs

Curie.Bio is giving biotech founders much smaller amounts of money at first and allowing them to maintain ownership stakes longer.

February 14, 2023 Check out STAT+

Sponsored By

Vanessa Leroy for STAT STAT+ | With $520 million in hand, two entrepreneurs try to upend the biotech funding model Curie.Bio is giving biotech founders much smaller amounts of money at first and allowing them to maintain ownership stakes longer. By Allison DeAngelis and Matthew Herper STAT+ | Medicare advisers suggest tweaks to coverage process for Alzheimer's drugs Medicare advisers want the program to tweak a process that has been used to restrict access to new Alzheimer's drugs. By Rachel Cohrs Scientific institutions must embrace antiracist policies, National Academies report urges Universities, the report finds, both need to increase underrepresented racial and ethnic groups in their ranks and change their cultures. By Andrew Joseph The Portal to Texas History How a Black veteran desegregated a Texas medical school STAT spoke with Vanessa Northington Gamble about Herman A. Barnett III, who desegrated a Texas medical school in 1949. By Theresa Gaffney Vape maker Elf Bar wants to donate to the American Cancer Society, but it doesn't want tobacco money Popular vape maker Elf Bar wanted to donate to the American Cancer Society. But the group doesn't want the money. By Nicholas Florko Opinion: The X-waiver for buprenorphine prescribing is gone. It's time to spread the word A new law eliminating the X-waiver for prescribing buprenorphine for opioid use disorder won't do much good if no one knows about it. By Beth S. Linas and Benjamin P. Linas Adobe Opinion: How to save three-quarters of a trillion dollars in health care costs A new report shows how Congress can reduce health care costs by more than $767 billion over the next 10 years. By Kim Keck

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser